Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Completed2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT02472054Phase 1/2Completed
Treatment of Familiar Lymphohistiocytosis
Hemophagocytic Lymphohistiocytosis (HLH)
StudydirectorStart date: 2015-06-29
NCT01410019Phase 1/2Completed
Gene Therapy for X-linked Severe Combined Immunodeficiency
X-linked Severe Combined Immunodeficiency
Studydirector

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Assistance Publique - Hôpitaux de Paris

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Gary Kleiner, MDPhD

University of Miami

Related
1 trials

Shared therapeutic areas:

X-Linked Combined Immunodeficiency Diseases
Similarity Score15%

Xuefeng He, Dr.

The First Affiliated Hospital of Soochow University

Related
1 trials

Shared therapeutic areas:

Hemophagocytic Lymphohistiocytosis (HLH)
Similarity Score15%

Morton J. Cowan, MD

UCSF Children's Hospital

Related
1 trials

Shared therapeutic areas:

X-Linked Combined Immunodeficiency Diseases
Similarity Score15%

Morton J. Cowan, MD

University of California, San Francisco

Related
4 trials

Shared therapeutic areas:

X-Linked Combined Immunodeficiency Diseases
Similarity Score15%

Robert A. Krance, MD

Baylor College of Medicine

Related
1 trials

Shared therapeutic areas:

Hemophagocytic Lymphohistiocytosis (HLH)
Similarity Score15%

Gunnar Lachmann, MD

Charité - Universitätsmedizin Berlin, Department of Anesthesiology and Operative Intensive Care Medicine

Related
1 trials

Shared therapeutic areas:

Hemophagocytic Lymphohistiocytosis (HLH)
Similarity Score15%

Richard J. O'Reilly, MD

Memorial Sloan Kettering Cancer Center

Related
3 trials

Shared therapeutic areas:

X-Linked Combined Immunodeficiency Diseases
Similarity Score15%

Lauri Burroughs

Fred Hutch/University of Washington Cancer Consortium

Related
3 trials

Shared therapeutic areas:

X-Linked Combined Immunodeficiency Diseases
Similarity Score15%

Suk S De Ravin, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
8 trials

Shared therapeutic areas:

X-Linked Combined Immunodeficiency Diseases
Similarity Score15%

Suk See DeRavin, M.D., Ph.D

National Institute of Allergy and Infectious Diseases (NIAID)

Related
1 trials

Shared therapeutic areas:

X-Linked Combined Immunodeficiency Diseases
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02472054Phase 1/2StudyDirector

Treatment of Familiar Lymphohistiocytosis

Hemophagocytic Lymphohistiocytosis (HLH)
Completed
NCT01410019Phase 1/2StudyDirector

Gene Therapy for X-linked Severe Combined Immunodeficiency

X-linked Severe Combined Immunodeficiency
Completed

All 2 trials loaded